Rhodanine derivatives as novel peroxisome proliferator-activated receptor γ agonists

Acta Pharmacologica Sinica

Volumn 28, Issue 12, 2007, Pages 2033-2039

  Liu, Qing ^a   Zhang, Yue Yun ^a   Lu, Hui Li ^a   Li, Qun Yi ^a   Zhou, Cai Hong ^a   Wang, Ming Wei ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Adipogenesis; Peroxisome proliferator activated receptor; Rhodanine derivatives; Structure activity relationship

Indexed keywords

LUCIFERASE; OXYGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PLASMID VECTOR; RETINOID X RECEPTOR ALPHA; RHODANINE; ROSIGLITAZONE; SH 00012671; STREPTAVIDIN; SULFUR;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; BINDING ASSAY; BIOTINYLATION; CELL ASSAY; CELL DIFFERENTIATION; CELL STRAIN 3T3; CERCOPITHECIDAE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; EXPRESSION VECTOR; HIGH THROUGHPUT SCREENING; IC 50; IN VITRO STUDY; KIDNEY CELL; NONHUMAN; RECEPTOR AFFINITY; REPORTER GENE; SCINTILLATION; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION; TRANSIENT TRANSFECTION;

ANIMALS; CELL LINE; MICE; PPAR GAMMA; RHODAMINES;

EID: 47149089690     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00657.x     Document Type: Article

References (18)

1. Wilson TM, Wahli W. Peroxisome proliferators-activated receptor agonists. Curr Opin Chem Biol 1997 1:235 41.
2. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology 1996 137:354 66.
3. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, et al. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 1994 91:7355 9.
4. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM. Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors. Nature 1992 358:771 4.
5. Ijpenberg A, Jeannin E, Wahli W, Desvergne B. Polarity and specific sequence requirements of PPAR-RXR heterodimer binding to DNA: a functional analysis of the malic enzyme gene PPRE. J Biol Chem 1997 272:20108 17.
6. Aubry CJ, Pernin A, Favez T, Burger AG, Wahli W, Meier CA, et al. DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements: importance of the 5′ flanking region. J Biol Chem 1997 272:25 252 9.
7. Keller JK, Collet P, Bianchi A, Huin C, Kremarik PB, Becuwe P, et al. Implications of peroxisome proliferator activated receptors (PPAR) in development, cell life status and disease. Int J Dev Biol 2000 44:429 42.
8. Sohda T, Momose Y, Meguro K, Kawamatsu Y, Sugiyama Y, Ikeada H. Studies on antidiabetic agents. Synthesis and hypoglycemic activity of 5-[4-(pyridylalkoxy)benzyl]-2,4-thiazolidine-diones. Arzneimittelforschung 1990 40:37 42.
9. Kletzien RF, Clarke SD, Ulrich RG. Enhancement of adipocyte differentiation by an insulin-sensitizing agent. Mol Pharmacol 1992 41:393 8.
10. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferators-activated receptor gamma (PPARy). J Biol Chem 1995 270:12 953 6.
11. Javiya VA, Patel JA. The role peroxisome proliferator-activated receptors in human disease. Edu Forum 2006 38:243 53.
12. Wu B, Gao J, Wang MW. Development of a complex scintillation proximity assay for high-throughput screening of PPARγ modulators. Acta Pharmacol Sin 2005 26:339 44.
13. Gearing KL, Göttlicher M, Teboul M, Widmark E, Gustafsson J. Inter-action of the peroxisome proliferator-activated receptor and retinoid X receptor. Proc Natl Acad Sci USA 1993 90:1440 4.
14. Tadashi S, Masaki O. Studies on sulfur-containing heterocyclic compounds. II. Reaction of potassium 3-benzoyldithiocarbazate and monochloroacetic acid and its ester. J Pharm Soc Japan 1955 75:1535 9.
15. 50) of an enzymatic reaction. Biochem Pharmacol 1973 22:3099 108.
16. Amit K, Sushil KK, Anil KS. QSAR and molecular modeling studies in imidazopyridinethiazolidine-2,4-diones: PPARγ agonists. Med Chem Res 2004 13:770 80.
17. Kwang RK, Jeong HL, Seung JK, Sang DR, Won HJ, Sung-Don Y, et al. KR-62980: A novel peroxisome proliferator-activated receptor γ agonist with weak adipogenic effects. Biochem Pharmacol 2006 72:446 54.
18. Béatrice D, Walter W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999 20:649 88.